Evidence map›Paper›PMID 38918376›Full record

ArticleNature communications2024

Structural and mechanistic insights into a lysosomal membrane enzyme HGSNAT involved in Sanfilippo syndrome.

Boyang Zhao, Zhongzheng Cao, Yi Zheng, Phuong Nguyen, Alisa Bowen, Robert H Edwards, Robert M Stroud, Yi Zhou, Menno Van Lookeren Campagne, Fei Li

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Boyang Zhao *Amgen Research, Department of Structural biology, South San Francisco, CA, USA.
Zhongzheng Cao *Amgen Research, Department of Inflammation, South San Francisco, CA, USA.
Yi ZhengAmgen Research, Department of Discovery Protein Science, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-4871-0779
Phuong NguyenDepartment of Biochemistry and Biophysics, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, USA.
Alisa BowenDepartment of Biochemistry and Biophysics, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-8518-6697
Robert H EdwardsDepartments of Neurology and Physiology, UCSF School of Medicine, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-8650-3260
Robert M StroudDepartment of Biochemistry and Biophysics, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-2083-5665
Yi ZhouAmgen Research, Department of Inflammation, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-1926-5290
Menno Van Lookeren CampagneAmgen Research, Department of Inflammation, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-3303-7294
Fei LiAmgen Research, Department of Structural biology, South San Francisco, CA, USA. fli05@amgen.com.ORCID http://orcid.org/0000-0003-0720-3129

Funding

STRUCTURE/FUNCTION OF PROTEINS AT MOLECULAR LEVELR01GM024485 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STROUD, ROBERT M · 1985 to 2024
$7.5M
Structural Basis of Vesicular Neurotransmitter TransportR01NS089713 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARDS, ROBERT H, STROUD, ROBERT M · 2015 to 2023
$5.8M
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Glutamate Transport into Synaptic VesiclesR01NS129803 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROBERT H EDWARDS · 2023 to 2026
$2.0M
Linux cluster for near atomic resolution single particle cryo-EMS10OD020054 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHENG, YIFAN · 2015 to 2015
$456k
Structural Basis of Quantal ReleaseK99MH119591 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LI, FEI · 2019 to 2020
$242k
NIGMS NIH HHS R01 GM024485NIGMS NIH HHS R01 GM129325NIH HHS S10 OD020054NIMH NIH HHS K99 MH119591NINDS NIH HHS R01 NS089713NINDS NIH HHS R01 NS129803U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) K99MH119591
6 · The paper itself

Abstract

Heparan sulfate (HS) is degraded in lysosome by a series of glycosidases. Before the glycosidases can act, the terminal glucosamine of HS must be acetylated by the integral lysosomal membrane enzyme heparan-α-glucosaminide N-acetyltransferase (HGSNAT). Mutations of HGSNAT cause HS accumulation and consequently mucopolysaccharidosis IIIC, a devastating lysosomal storage disease characterized by progressive neurological deterioration and early death where no treatment is available. HGSNAT catalyzes a unique transmembrane acetylation reaction where the acetyl group of cytosolic acetyl-CoA is transported across the lysosomal membrane and attached to HS in one reaction. However, the reaction mechanism remains elusive. Here we report six cryo-EM structures of HGSNAT along the reaction pathway. These structures reveal a dimer arrangement and a unique structural fold, which enables the elucidation of the reaction mechanism. We find that a central pore within each monomer traverses the membrane and controls access of cytosolic acetyl-CoA to the active site at its luminal mouth where glucosamine binds. A histidine-aspartic acid catalytic dyad catalyzes the transfer reaction via a ternary complex mechanism. Furthermore, the structures allow the mapping of disease-causing variants and reveal their potential impact on the function, thus creating a framework to guide structure-based drug discovery efforts.

Indexed as

AcetyltransferasesCryoelectron MicroscopyLysosomesMucopolysaccharidosis IIIAcetylationAcetyl Coenzyme ACatalytic DomainGlucosamineHeparan SulfateHumansIntracellular MembranesModels, MolecularMutationAcetyl Coenzyme AAcetyltransferasesGlucosamineHeparan SulfateHGSNAT protein, human

Identifiers

PMID38918376
PMCPMC11199644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.